DSM Capital Partners, Coordinated Financial Services, L. Roy Papp & Associates, and numerous other financial firms have shifted their positions in Stryker Corporation's stock ($SYK). While some have raised their stake, others have lowered their position. Notably, the company recently opened a significant R&D hub in India, designed to accelerate advancements in AI and Robotics. Despite reporting strong growth amid supply chain challenges during their Q2 2025 earnings call, the corporation's share price fell. Expert analyst Jim Cramer expressed a lack of enthusiasm towards the corporation, while TD Cowen maintains a 'buy' on SYK with a $435 target. Ken Fisher, the billionaire investor, identified SYK among his health care stock picks. Despite its ever-increasing stakes, Stryker Corporation's stock faced a fall after its Q2 earnings and sales beat. However, the company continues to beat expectations repeatedly, indicating its strength. The corporation has planned their Q3 2025 earnings release, signaling another critical milestone for investors.
Stryker Corporation SYK News Analytics from Sun, 27 Apr 2025 07:00:00 GMT to Sat, 11 Oct 2025 10:50:11 GMT -
Rating 6
- Innovation 7
- Information 9
- Rumor 1
